Logistics & Transportation

Articles

Goal of the deal is to boost the production of oral dosage forms.

The 50,000 square-foot facility will feature 10 new manufacturing sites with commercial capabilities.

Platform is expected to streamline the label management process. 

Initiative to support developing manufacturers launch new products. 

According to a recent TMR study, there is an expected CAGR increase of 5.6%.

The 200,000 square-foot manufacturing plant—coming early next year—is expected to help boost capacity of pharma packaging materials.

The series’ marking heads help deliver codes to support both product traceability and anti-counterfeiting efforts. 

Expansion expected to create additional production capacity, company says.

Changes to 3PL’s facility feature newly-converted controlled room temperature pallets.    

CDMO’s new facility is expected to be operational by April 2025.